Literature DB >> 28720493

Crystal structures of monkey and mouse nicotinamide N-methyltransferase (NNMT) bound with end product, 1-methyl nicotinamide.

Srinivasan Swaminathan1, Swarnakumari Birudukota1, Manish Kumar Thakur1, Reejuana Parveen1, Saravanan Kandan1, Suresh Juluri2, Shama Shaik2, Niranjan Naranapura Anand2, Raghunadha Reddy Burri3, Rajendra Kristam3, Mahanandeesha Siddappa Hallur4, Sridharan Rajagopal4, Herman Schreuder5, Thomas Langer5, Christine Rudolph5, Sven Ruf5, Saravanakumar Dhakshinamoorthy2, Ramachandraiah Gosu6, Aimo Kannt7.   

Abstract

Nicotinamide N-methyltransferase (NNMT) is a S-adenosyl-l-methionine (SAM)-dependent enzyme that catalyzes N-methylation of nicotinamide (NA) and other pyridines to form N-methyl pyridinium ions. Here we report the first ternary complex X-ray crystal structures of monkey NNMT and mouse NNMT in bound form with the primary endogenous product, 1-methyl nicotinamide (MNA) and demethylated cofactor, S-adenosyl-homocysteine (SAH) determined at 2.30 Å and 1.88 Å respectively. The structural fold of these enzymes is identical to human NNMT. It is known that the primary endogenous product catalyzed by NNMT, MNA is a specific inhibitor of NNMT. Our data clearly indicates that the MNA binds to the active site and it would be trapped in the active site due to the formation of the bridge between the pole (long helix, α3) and long C-terminal loop. This might explain the mechanism of MNA acting as a feedback inhibitor of NNMT.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Feedback inhibition; MNA; NA; NNMT; Ternary complex

Mesh:

Substances:

Year:  2017        PMID: 28720493     DOI: 10.1016/j.bbrc.2017.07.087

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  Discovery of Bisubstrate Inhibitors of Nicotinamide N-Methyltransferase (NNMT).

Authors:  Nicolas Babault; Abdellah Allali-Hassani; Fengling Li; Jie Fan; Alex Yue; Kevin Ju; Feng Liu; Masoud Vedadi; Jing Liu; Jian Jin
Journal:  J Med Chem       Date:  2018-01-31       Impact factor: 7.446

Review 2.  Nicotinamide N-Methyltransferase: A Promising Biomarker and Target for Human Cancer Therapy.

Authors:  Xiao-Yu Li; Ya-Nan Pi; Yao Chen; Qi Zhu; Bai-Rong Xia
Journal:  Front Oncol       Date:  2022-06-09       Impact factor: 5.738

3.  A small molecule inhibitor of Nicotinamide N-methyltransferase for the treatment of metabolic disorders.

Authors:  Aimo Kannt; Sridharan Rajagopal; Sanjay Venkatachalapathi Kadnur; Juluri Suresh; Ravi Kanth Bhamidipati; Srinivasan Swaminathan; Mahanandeesha Siddappa Hallur; Rajendra Kristam; Ralf Elvert; Jörg Czech; Anja Pfenninger; Christine Rudolph; Herman Schreuder; Devaraj Venkatapura Chandrasekar; Vishal Subhash Mane; Swarnakumari Birudukota; Shama Shaik; Bharat Ravindra Zope; Raghunadha Reddy Burri; Niranjan Naranapura Anand; Manish Kumar Thakur; Manvi Singh; Reejuana Parveen; Saravanan Kandan; Ramesh Mullangi; Takeshi Yura; Ramachandraiah Gosu; Sven Ruf; Saravanakumar Dhakshinamoorthy
Journal:  Sci Rep       Date:  2018-02-26       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.